Most cited papers from Omuta hospital

Omuta hospital

What are the most cited papers from Omuta hospital?

The most cited paper from Omuta hospital is "Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention" (Kenichi Tsujita et al., 2015), with 456 citations. Next come "Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders" (299) and "Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs" (232).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 43 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention Kenichi Tsujita et al. · Journal of the American College of Cardiology Open access	27 Jul 2015	456
2	Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders Shuichi Yatsuga, Yasunori Fujita, Akiko Ishii et al. · Annals of Neurology Open access	14 Oct 2015	299
3	Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs Ana Dioun Broyles et al. · The Journal of Allergy and Clinical Immunology In Practice	Oct 2020	232
4	HLA‐B1511 is a risk factor for carbamazepine‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in Japanese patients Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara et al. · Epilepsia* Open access	3 Nov 2010	229
5	Evaluation of Urinary 8-Hydroxydeoxy-Guanosine as a Novel Biomarker of Macrovascular Complications in Type 2 Diabetes Takeshi Nishikawa, Takayuki Sasahara, Shinsuke Kiritoshi et al. · Diabetes Care Open access	May 2003	194
6	A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients Masahiro Tohkin, Nahoko Kaniwa, Yoshiro Saito et al. · The Pharmacogenomics Journal	13 Sep 2011	186
7	Clinical and Microbiological Differences between Mycobacterium abscessus and Mycobacterium massiliense Lung Diseases Toshiyuki Harada, Yasushi Akiyama, Atsuyuki Kurashima et al. · Journal of Clinical Microbiology Open access	22 Aug 2012	176
8	Effects of cigarette smoke on barrier function and tight junction proteins in the bronchial epithelium: protective role of cathelicidin LL-37 Miyoko Tatsuta, Keiko Kan‐o, Yumiko Ishii et al. · Respiratory Research Open access	9 Nov 2019	158
9	Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma ? a comparison of lipiodol-transcatheter arterial embolization with and without Adriamycin (first cooperative study) Saburo Kawai et al. · Cancer Chemotherapy and Pharmacology	1992	148
10	Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16 Akiko Iwaki, Yu Kawano, Shiroh Miura et al. · Journal of Medical Genetics	11 Oct 2007	144
11	Quantitation of the Global Right Ventricular Function in Children with Normal Heart and Congenital Heart Disease: A Right Ventricular Myocardial Performance Index Masahiro Ishii, Genjyu Eto, Chuwa Tei et al. · Pediatric Cardiology	Sep 2000	139
12	Prognostic value of serial serum KL-6 measurements in patients with idiopathic pulmonary fibrosis Kentaro Wakamatsu, Nobuhiko Nagata, Hiroyuki Kumazoe et al. · Respiratory Investigation	9 Nov 2016	122
13	Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan Toshio Shimizu, Utako Nagaoka, Yuki Nakayama et al. · Amyotrophic Lateral Sclerosis	28 May 2012	115
14	Impaired Food Transportation in Parkinson’s Disease Related to Lingual Bradykinesia George Umemoto, Yoshio Tsuboi, Akio Kitashima et al. · Dysphagia	28 Aug 2010	111
15	Clinical study of childhood acute disseminated encephalomyelitis, multiple sclerosis, and acute transverse myelitis in Fukuoka Prefecture, Japan Hiroyuki Torisu et al. · Brain and Development Open access	27 Nov 2009	109
16	Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis Kentaro Watanabe, Nobuhiko Nagata, Yasuhiko Kitasato et al. · Respiratory Investigation	Aug 2012	102
17	HPGCD Outperforms HPBCD as a Potential Treatment for Niemann-Pick Disease Type C During Disease Modeling with iPS Cells Minami Soga, Yoichi Ishitsuka, Makoto Hamasaki et al. · Stem Cells	19 Dec 2014	102
18	Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation Takahisa Tateishi, Toshihiro Hokonohara, Ryo Yamasaki et al. · Acta Neuropathologica	4 Dec 2009	101
19	A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H) Hirokazu Furuya, Koji Ikezoe, Lixiang Wang et al. · American Journal of Medical Genetics Part A	17 Jan 2008	90
20	The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis Taishi Harada, Yūji Yoshida, Yasuhiko Kitasato et al. · European Respiratory Review Open access	31 May 2014	87
21	SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F Fatma Ayhan, Barbara A. Perez, Hannah K. Shorrock et al. · The EMBO Journal Open access	11 Sep 2018	81
22	Clinical Significance of Adverse Events for Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki et al. · Cancers Open access	11 Jul 2020	79
23	Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis Kimiko Kuroki, Naoyuki Tsuchiya, Mitsunori Shiroishi et al. · Human Molecular Genetics	13 Jul 2005	79
24	Pathomorphology of Esophageal and Gastric Varices Masaaki Arakawa, Takao Masuzaki, Kunio Okuda · Seminars in Liver Disease	2002	78
25	Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma Takuji Okusaka, Shuichi Okada, Toshio Nakanishi et al. · Investigational New Drugs	16 Jan 2004	77
26	Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B Toshinari Takahashi et al. · Journal of Neurology Neurosurgery & Psychiatry Open access	15 Dec 2012	76
27	Long-term recovery of exercise capacity and pulmonary function after lobectomy Yoshinori Nagamatsu, Kanetaka Maeshiro, Norman Y. Kimura et al. · Journal of Thoracic and Cardiovascular Surgery Open access	Nov 2007	76
28	Specific HLA Types are Associated with Antiepileptic Drug-Induced Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Japanese Subjects Nahoko Kaniwa et al. · Pharmacogenomics	Nov 2013	72
29	Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review) Kiyoshi Kikuchi, Nobuyuki Takeshige, Naoki Miura et al. · Experimental and Therapeutic Medicine Open access	20 Sep 2011	71
30	Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses Hiroyuki Ishiura, Yuji Takahashi, Toshihiro Hayashi et al. · Journal of Human Genetics Open access	23 Jan 2014	70
31	FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion Naoki Suzuki, Masashi Aoki, Hitoshi Warita et al. · Journal of Human Genetics	12 Mar 2010	70
32	IL-38: A new factor in rheumatoid arthritis Shinichi Takenaka, Shinjiro Kaieda, Tomotaka Kawayama et al. · Biochemistry and Biophysics Reports Open access	30 Oct 2015	69
33	Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4 Kiyoshi Kikuchi et al. · Biochemical and Biophysical Research Communications	7 Sep 2009	68
34	Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis Yūji Yoshida, Nobuhiko Nagata, Nobuko Tsuruta et al. · Respiratory Investigation	29 Dec 2015	67
35	A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor Toru Fukuda et al. · Biochemical and Biophysical Research Communications	25 Oct 2008	67
36	Pathologic stage I non–small cell lung cancer with high levels of preoperative serum carcinoembryonic antigen: Clinicopathologic characteristics and prognosis Haruhisa Matsuguma, Rie Nakahara, Seiji Igarashi et al. · Journal of Thoracic and Cardiovascular Surgery Open access	2008	65
37	Lenvatinib prolongs the progression‑free survival time of patients with intermediate‑stage hepatocellular carcinoma refractory to transarterial chemoembolization: A multicenter cohort study using data mining analysis Shigeo Shimose, Takumi Kawaguchi, Masatoshi Tanaka et al. · Oncology Letters Open access	19 Jun 2020	64
38	Pathogenic Mutation of ALK2 Inhibits Induced Pluripotent Stem Cell Reprogramming and Maintenance: Mechanisms of Reprogramming and Strategy for Drug Identification Makoto Hamasaki, Yoshinobu Hashizume, Yoshinori Yamada et al. · Stem Cells	4 Sep 2012	64
39	Endoplasmic reticulum stress in myotonic dystrophy type 1 muscle Koji Ikezoe, Masayuki Nakamori, Hirokazu Furuya et al. · Acta Neuropathologica Open access	27 Jul 2007	64
40	Prognostic stratification of patients with nasopharyngeal carcinoma based on tumor immune microenvironment Takeharu Ono, Koichi Azuma, Akihiko Kawahara et al. · Head & Neck	13 May 2018	63
41	Hydrogen Sulfide Production From Cysteine and Homocysteine by Periodontal and Oral Bacteria Akihiro Yoshida, Mamiko Yoshimura, Naoya Ohara et al. · Journal of Periodontology	Nov 2009	62
42	Establishing diagnostic criteria for Perry syndrome Takayasu Mishima, Shinsuke Fujioka, Hiroyuki Tomiyama et al. · Journal of Neurology Neurosurgery & Psychiatry Open access	31 Oct 2017	60
43	Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP ‐43‐positive inclusions Hiroyuki Honda, Hideomi Hamasaki, Tomihiro Wakamiya et al. · Neuropathology	22 Oct 2014	60
44	Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka et al. · Cancers Open access	5 Jan 2021	57
45	The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025) Yusuke Ohya et al. · Hypertension Research	2026	56
46	Clinicopathologic Features of Oculopharyngodistal Myopathy WithLRP12CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes Theerawat Kumutpongpanich et al. · JAMA Neurology Open access	28 May 2021	55
47	Sporadic juvenile amyotrophic lateral sclerosis caused by mutant FUS/TLS: possible association of mental retardation with this mutation Satoshi Yamashita, Akira S. Mori, Hideya Sakaguchi et al. · Journal of Neurology	4 Nov 2011	55
48	A polymorphism in CCR1/CCR3 is associated with narcolepsy Hiromi Toyoda et al. · Brain Behavior and Immunity	15 May 2015	54
49	Distal tuberosity osteotomy in open-wedge high tibial osteotomy does not exacerbate patellofemoral osteoarthritis on arthroscopic evaluation Tomohiro Horikawa, Kenji Kubota, Shintaro Hara et al. · Knee Surgery Sports Traumatology Arthroscopy	28 Jun 2019	53
50	“Reversed Halo Sign” of High-resolution Computed Tomography in Pulmonary Sarcoidosis Hiroyuki Kumazoe, Kazuko Matsunaga, Nobuhiko Nagata et al. · Journal of Thoracic Imaging	Feb 2009	53

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.